- Home
- RM vs GOSS Comparison
RM vs GOSS Comparison
Compare RM & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RM
- GOSS
- Stock Information
- Founded
- RM 1987
- GOSS 2015
- Country
- RM United States
- GOSS United States
- Employees
- RM 2131
- GOSS N/A
- Industry
- RM Finance: Consumer Services
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- RM Finance
- GOSS Health Care
- Exchange
- RM Nasdaq
- GOSS Nasdaq
- Market Cap
- RM 314.9M
- GOSS 347.8M
- IPO Year
- RM 2012
- GOSS 2019
- Fundamental
- Price
- RM $31.17
- GOSS $1.96
- Analyst Decision
- RM Hold
- GOSS Strong Buy
- Analyst Count
- RM 2
- GOSS 4
- Target Price
- RM $30.00
- GOSS $8.25
- AVG Volume (30 Days)
- RM 37.6K
- GOSS 2.6M
- Earning Date
- RM 07-30-2025
- GOSS 08-11-2025
- Dividend Yield
- RM 3.78%
- GOSS N/A
- EPS Growth
- RM 41.13
- GOSS N/A
- EPS
- RM 3.29
- GOSS N/A
- Revenue
- RM $577,647,000.00
- GOSS $124,590,000.00
- Revenue This Year
- RM $13.10
- GOSS N/A
- Revenue Next Year
- RM $9.35
- GOSS $65.50
- P/E Ratio
- RM $9.63
- GOSS N/A
- Revenue Growth
- RM 6.45
- GOSS N/A
- 52 Week Low
- RM $25.41
- GOSS $0.66
- 52 Week High
- RM $37.52
- GOSS $2.18
- Technical
- Relative Strength Index (RSI)
- RM 48.20
- GOSS 73.23
- Support Level
- RM $31.52
- GOSS $1.72
- Resistance Level
- RM $33.50
- GOSS $1.94
- Average True Range (ATR)
- RM 0.90
- GOSS 0.16
- MACD
- RM -0.27
- GOSS 0.04
- Stochastic Oscillator
- RM 10.04
- GOSS 75.00
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.